Mustang Bio’s MB-101 Gallops To Win In Glioblastoma

The lead author on the Phase I study told Scrip that in addition to targeting a widely expressed antigen on GBM tumors, the CAR-T also stimulates the body’s immune system.

• Source: Shutterstock

More from Immuno-oncology

More from Anticancer